Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon B Wigal

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Psychiatry (Edgmont (Pa. : Township))|May 29, 2010
Real-World Data on: Attention Deficit Hyperactivity Disorder Medication Side EffectsElisa Cascade, Amir H Kalali, Sharon B Wigal
Journal of Biomedical Optics|December 13, 2012
Phase synchronization of oxygenation waves in the frontal areas of children with attention-deficit hyperactivity disorder detected by optical diffusion spectroscopy correlates with medicationSharon B Wigal, Chiara M Polzonetti, Annamarie Stehli, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2011
Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorderSharon B Wigal, Suneel Gupta, Erica Heverin, et al.
Seminars in Pediatric Neurology|December 25, 2010
Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologistsSharon B Wigal, Stephanie Chae, Avni Patel, et al.
Journal of Attention Disorders|August 7, 2012
Exercise: applications to childhood ADHDSharon B Wigal, Natasha Emmerson, Jean-G Gehricke, et al.
Pediatrics|June 6, 2007
Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study resultsSharon B Wigal, Timothy E Wilens, Mark Wolraich, et al.
Child and Adolescent Psychiatry and Mental Health|June 11, 2009
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderSharon B Wigal, Scott H Kollins, Ann C Childress, et al.
Journal of Child and Adolescent Psychopharmacology|September 2, 2008
Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom studyDavid Pierce, Catherine M Dixon, Sharon B Wigal, et al.
Child and Adolescent Psychiatry and Mental Health|December 16, 2010
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the daySharon B Wigal, Scott H Kollins, Ann C Childress, et al.
Journal of Child and Adolescent Psychopharmacology|January 8, 2013
NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom studySharon B Wigal, Ann C Childress, Heidi W Belden, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Psychiatry (Edgmont (Pa. : Township))|May 29, 2010
Real-World Data on: Attention Deficit Hyperactivity Disorder Medication Side EffectsElisa Cascade, Amir H Kalali, Sharon B Wigal
Journal of Biomedical Optics|December 13, 2012
Phase synchronization of oxygenation waves in the frontal areas of children with attention-deficit hyperactivity disorder detected by optical diffusion spectroscopy correlates with medicationSharon B Wigal, Chiara M Polzonetti, Annamarie Stehli, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2011
Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorderSharon B Wigal, Suneel Gupta, Erica Heverin, et al.
Seminars in Pediatric Neurology|December 25, 2010
Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologistsSharon B Wigal, Stephanie Chae, Avni Patel, et al.
Journal of Attention Disorders|August 7, 2012
Exercise: applications to childhood ADHDSharon B Wigal, Natasha Emmerson, Jean-G Gehricke, et al.
Pediatrics|June 6, 2007
Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit/hyperactivity disorder: 2-year, open-label study resultsSharon B Wigal, Timothy E Wilens, Mark Wolraich, et al.
Child and Adolescent Psychiatry and Mental Health|June 11, 2009
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderSharon B Wigal, Scott H Kollins, Ann C Childress, et al.
Journal of Child and Adolescent Psychopharmacology|September 2, 2008
Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom studyDavid Pierce, Catherine M Dixon, Sharon B Wigal, et al.
Child and Adolescent Psychiatry and Mental Health|December 16, 2010
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the daySharon B Wigal, Scott H Kollins, Ann C Childress, et al.
Journal of Child and Adolescent Psychopharmacology|January 8, 2013
NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom studySharon B Wigal, Ann C Childress, Heidi W Belden, et al.
Pageof 7